Research

This cross-sectional study analyzed data from a telehealth OUD treatment provider group currently operating in 32 states to assess the extent of buprenorphine availability at local pharmacies.

Americans have benefited substantially from new medical treatments, and the United States serves as the engine of medical innovation for the world.

MRI and CSF biomarkers, while important for understanding dementia pathology in clinical research, were not found to substantially improve cognitive status classification based on cognitive status performance.

Despite efforts to address the opioid crisis, opioid-related overdoses remain a significant contributor to mortality.

The national hepatitis C elimination initiative would substantially reduce HCV-related morbidity and mortality and would reduce healthcare spending at 10 years and beyond.

Providing primary care clinicians with suitable assessment tools, integrating brief cognitive assessments into routine workflows, and crafting payment policies to encourage adoption of assessments would all help improve detection.

The cumulative social benefits from Medicare coverage for new obesity treatments over the next 10 years would reach almost $1 trillion, or roughly $100 billion per year.

Parents’ perceptions of the COVID-19 vaccine’s long-term comparative risk and their greater anticipated responsibility for children getting sick if vaccinated (versus not) were associated with lower vaccine uptake among children of vaccinated parents.

This paper provides three recommendations to steer the potential effects of the IRA toward its goal of improving patient access while encouraging innovation.

The majority of Healthcare stereotype threat experiences were connected to the social identities of sexual orientation, HIV status, and age.